Agios Pharmaceuticals
AGIO
AGIO
214 hedge funds and large institutions have $2.3B invested in Agios Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 60 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
23% less call options, than puts
Call options by funds: $7.7M | Put options by funds: $9.96M
36% less capital invested
Capital invested by funds: $3.61B → $2.3B (-$1.31B)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
214
Holding in Top 10
1
Calls
$7.7M
Puts
$9.96M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$16.8M | |
| 3 | +$14.1M | |
| 4 |
Morgan Stanley
New York
|
+$13.8M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.2M |
Top Sellers
| 1 | -$62.6M | |
| 2 | -$48.1M | |
| 3 | -$42.6M | |
| 4 |
Alkeon Capital Management
New York
|
-$26.3M |
| 5 |
AG
Artal Group
Luxembourg
|
-$20.1M |